Amanda Richard
Family · Emmetsburg, IANPI 1972086668
Payments from drug & device makers
Across 106 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$339
- E.r. Squibb & Sons, L.L.C.$240
- Novo Nordisk$170
- Pfizer$166
- Amgen$153
- Novartis$103
- plus $487 from 12 others
What the payments were for
- Food & beverage$1,64499%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 22 | $339 |
| E.r. Squibb & Sons, L.L.C. | 15 | $240 |
| Novo Nordisk | 10 | $170 |
| Pfizer | 9 | $166 |
| Amgen | 10 | $153 |
| Novartis | 8 | $103 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Exact Sciences | 5 | $72 |
| Mylan Specialty L.p. | 4 | $68 |
| AbbVie | 3 | $59 |
| AstraZeneca | 4 | $51 |
| Bayer | 3 | $47 |
| Boehringer Ingelheim | 3 | $44 |
| Viatris Specialty LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Alkermes, Inc. | 1 | $12 |
How this compares
$1,658 in reported general payments places this provider in the 85th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 72 | $93,773 |
| EliquisApixaban | 92 | $74,173 |
| MounjaroTirzepatide | 60 | $64,213 |
| JardianceEmpagliflozin | 44 | $54,029 |
| FarxigaDapagliflozin Propanediol | 48 | $34,565 |
| OzempicSemaglutide | 21 | $19,065 |
| JanuviaSitagliptin Phosphate | 23 | $18,775 |
| MyrbetriqMirabegron | 21 | $11,090 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,584 |
| Incruse ElliptaUmeclidinium Bromide | 20 | $6,618 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 21 | $5,588 |
| Potassium Chloride | 177 | $5,030 |
| Metoprolol Succinate | 214 | $3,179 |
| Colestipol Hcl | 33 | $2,862 |
| Atorvastatin Calcium | 418 | $2,751 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $339 | $157,986132 claims |
| PfizerEliquis | $166 | $74,17392 claims |
| Boehringer IngelheimJardiance | $44 | $54,02944 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $51 | $45,14964 claims |
| Novo NordiskOzempic | $170 | $19,06521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,268 family providers in Iowa.
Other family in Emmetsburg
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.